Listing 1 - 10 of 24 << page
of 3
>>
Sort by
The CDER reference guide
Authors: ---
Publisher: Silver Spring, MD : Center for Drug Evaluation and Research

Loading...
Export citation

Choose an application

Bookmark

Abstract

Organizational charts and contact information for the Center for Drug Evaluation and Research.


Book
Report of the Secretary of Agriculture
Authors: ---
Year: 2000 Publisher: Washington, DC : USDA,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Undated report by Raymond C. Scott, Assistant Administrator in the Federal Extension Service, about the work that the USDA and the Extension Service have done to help physically and intellectually handicapped people.


Periodical
Public personnel management.
Authors: ---
ISSN: 00910260 19457421 Year: 1973 Publisher: [Washington, D.C., etc.] [International Personnel Management Association]

Loading...
Export citation

Choose an application

Bookmark

Abstract

The Public Personnel Management Journal is specifically designed for human resources professionals who work in the public sector. Each issue features in-depth articles on trends, case studies, and the latest research for the public sector human resources community.


Book
AHRQ tools for managed care
Authors: ---
Year: 2003 Publisher: Rockville, Md. : Agency for Healthcare Research and Quality,

Loading...
Export citation

Choose an application

Bookmark

Abstract

The Agency for Healthcare Research and Quality (AHRQ) has funded research to compile a database of evidence-based clinical guidelines and to develop clinical performance measures, member satisfaction surveys, and preventive care recommendations that can help MCOs meet their responsibilities. Additionally, AHRQ funds research and develops performance measures and guidelines that managed care organizations, insurers, providers, and consumers can trust.


Book
Proceedings from enhancing interactions to reduce cancer health disparities, an NCI-wide workshop : including a proposed action plan to achieve the NCI strategic priority, overcome cancer health disparities.
Authors: ---
Year: 2006 Publisher: [Bethesda, MD] : U.S. Dept. of Health and Human Services, National Institutes of Health, National Cancer Institute,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Proceedings from enhancing interactions to reduce cancer health disparities evolved from an NCI-wide workshop held November 17 and 18, 2005 on the NIH campus involving more than 250 participants from virtually every NCI division, office, and center. The purpose of the workshop was to convene representatives from the entire Institute to take stock of the health disparities programs, studies, and initiatives that are being implemented across NCI; encourage trans-institute collaborations; and propose overarching objectives and feasible action plans for reducing cancer health disparities. These objectives and action plans provide a foundation for developing a business plan that: aligns with NCI's priority of overcoming cancer health disparities in the 2006 Strategic Plan, and contributes to achieving the NCI Challenge Goal of eliminating suffering and death due to cancer for all Americans.


Book
AHRQ tools and resources for better health care
Authors: ---
Year: 2002 Publisher: Rockville, Md : Agency for Healthcare Research and Quality,

Loading...
Export citation

Choose an application

Bookmark

Abstract

The Agency for Healthcare Research and Quality (AHRQ) has devoted significant funding to the creation of tools and resources that will help meet the needs of the U.S. health care system. This report briefly describes the tools and resources that AHRQ has made available, such as data sets, assessment and performance measures, clinical care guidelines, and quality measurement indicators. Examples of how these tools and resources are being used by federal, state, and local governments; private industry; health service providers; hospital associations; and health maintenance organizations to improve health care quality and help consumers make more informed choices are also provided.


Book
L'emploi public : un etat des lieux.
Authors: ---
ISBN: 9789264048003 9264048006 9264055908 Year: 2008 Publisher: Paris : OCDE,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Au cours des 20 dernières années, la gestion de l’emploi public a évolué de façon spectaculaire dans la plupart des pays de l’OCDE. Premièrement, les gouvernements se sont efforcés de réduire sa taille afin de diminuer les coûts de la production de services publics, soit directement, soit indirectement en sous-traitant la prestation de services au secteur privé dans la recherche d’une plus grande efficacité. Deuxièmement, dans nombre de cas, les gouvernements ont tenté d’appliquer les bons principes de gestion à la gestion de la fonction publique. C’est ainsi que l’emploi public dans nombre de secteurs de l’administration a perdu son caractère unique et est devenu assez semblable au système d’emploi général des différents pays. Cette publication dresse un bilan des principaux changements intervenus dans la gestion de l’emploi public dans les pays de l’OCDE. Elle examine également la manière dont les pays trouvent un équilibre entre, d’une part, le soutien des valeurs fondamentales comme l’équité, la justice et la cohésion sociale, de façon à préserver la confiance politique dans l’ensemble de l’appareil gouvernemental et, de l’autre, l’attention à l’efficience, à la productivité et à l’efficacité.


Book
Discretion and Public Benefit in a Regulatory Agency: The Australian Authorisation Process
Author:
ISBN: 1922144355 1922144363 9781922144362 9781922144355 Year: 2013 Publisher: ANU Press

Loading...
Export citation

Choose an application

Bookmark

Abstract

This book explores the manner in which a variety of public benefits such as environmental protection and consumer safety have been accommodated through the authorisation process within competition law and policy in Australia.


Book
National Institute of Allergy and Infectious Diseases, NIH.
Authors: --- ---
ISBN: 1603272968 9786612331145 1282331140 1603272976 Year: 2009 Publisher: Totowa, NJ : Humana Press,

Loading...
Export citation

Choose an application

Bookmark

Abstract

I N F E C T I O U S D I S E A S E® Vassil St. Georgiev, Series Editor National Institute of Allergy and Infectious Diseases, NIH Volume 2: Impact on Global Health Vassil St. Georgiev, PhD with Foreword by Antony S. Fauci, MD National Institute of Allergy and Infectious Diseases, National Institutes of Health, DHHS, Bethesda, MD For more than 50 years, the mission of the national Institute of Allergy and Infectious Disease (NIAID)has been to conduct and support basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases with the ultimate goal of improving the health of individuals in the United States and around the world. As part of its mission to foster biomedical research and to reduce the burden of human disease, NIAID is committed to encouraging the accelerated translation of biomedical discoveries into effective clinical care and public throughout the world. In pursuit of this goal and its disease-specific scientific objectives, NIAID seeks to broaden its global impact by increasing scientific opportunities and collaborations involving scientists and institutions outside the United States. The ever increasing efforts of NIAID to combat the worldwide HIV/AIDS, malaria, as well as the increasing numbers of humans infected by highly virulent strains of avian influenza in Asia and elsewhere. NIAID is at the forefront of efforts to address these and other international health challenges by supporting programs in approximately 90 countries and to have dramatically increased spending on international activities in the past decade in a clear strategy to not only devote more resources within the United States to the study of diseases with global health importance, but also to develop the capacity for advanced research within resource-poor nations. Extensive and in-depth, National Institute of Allergy and Infectious Diseases, NIH: Volume 2, Impact on Global Health is a valuable and comprehensive guide providing up-to-date accounts on the state of specific research endeavors in the areas of microbiology and infectious diseases (other than AIDS), HIV/AIDS, allergy, immunology, and transplantation, covering the research portfolios of the NIAID’s extramural divisions of Microbiology and Infectious Diseases, AIDS, and Allergy, Immunology and Transplantation. This volume comprises documents of the United States Government and other research information that is in the public domain. Nevertheless, this volume is not an official U.S. Government publication. Features Includes detailed up-to-date overviews of specific research endeavors in microbiology and infectious diseases (other than HIV/AID), HIV/AIDS, allergy, immunology, and transplantation. Contents Foreword: Anthony S. Fauci, MD. Part I. Microbiology and Infectious Diseases. Primary Research Areas in Microbiology and Infectious Diseases (non-HIV/AIDS). NIAID International Research Programs: Global Impact: Africa, Asia, Partnerships. Bacterial Diseases. Emerging and Re-Emerging Infectious Diseases. Fungal Diseases. Tropical Medicine and Parasitic Diseases. Virology. Sexually-Transmitted Diseases. Enteric Diseases. Respiratory Diaeases. Streptococcus pneumoniae (Pneumococcal) Disease. Severe Acute Respiratory Syndrome (SARS). Influenza. Tuberculosis. Viral Hepatitis. West Nile Virus. Herpesviruses. Paramyxoviridae: Nipah Virus and Hendra Virus. Arthropod-Borne Viral Encephalitis: Flaviviruses, Aphaviruses, Bunyaviruses. Malaria. Rickettsia: The Typhus Group. Tick-Borne Bacterial, Rickettsial, Spirochetal, and Protozoal Diseases: Lyme Disease,Tick-Borne Rickettsial Diseases, Tularemia, Souther Tick-Associated Rash Illness, Babesiosis, Tick-Borne Relapsing Fever. Defense against Biological Weapons (Biodefense): History of Biological Warfare, Anthrax, Variola major Virus (Smallpox), Yersinia pestis (Plague), Brucellosis, Coxiella burnetii-Q fever, Glanders, Melioidosis, Viral Hemorrhagic Fever: Filoviruses, Viral Hemorrhagic Fever: Bunyaviridae, Viral Hemorrhagic Fever: Arenaviruses, Viral Hemorrhagic Fever: Flaviviruses, Protein Toxin Weapons, Arthropod-Borne Viral Fever and Arthropathy, NIAID Research Agenda in Biodefense Antimicrobial Resistance and Healthcare-Acquired Infections. Genomic and Post-Genomic Research. Drug Development Research. Part II. Human Immunodeficiency Virus and Acquired Immunodeficiency Syndrome. Introduction: Human Immunodeficiency Virus (HIV). NIAID: Programs in HIV Prevention: Clinical Trials. NIAID: Programs in HIV/AIDS Therapeutics: Drug Discovery, Preclinical Drug Development, Clinical Research, Resources for Researchers, NIAID Funding Initiatives, Clinical Trials, Other NIH-Funded Clinical Trials Networks, Clinical Trials Guidelines. NIAID: Programs in HIV Vaccines. NIAID: International Involvement in HIV/AIDS Research: Clinical Trial Network Studies- ACTG, HVTN, IMPAACT, INSIGHT, MTN, Non-Clinical Trial Network Studies, Centers for AIDS Research (CFARs), Comprehensive International Program of Research on AIDS (CIPRA), International Databases to Evaluate AIDS (IeDEA), Male Circumcision, NIAID Collaborative International Research, U.S. Military HIV Research Program (USMHRP) Trials funded by NIAID, Other HIV/AIDS Vaccine Related Work, International AIDS Vaccine Initiative (IAVI), Partnership for AIDS Vaccine Evaluation (PAVE), Center for HIV/AIDS Vaccine Immunology (CHAVI), Global HIV Vaccine Enterprise (GHVE), President’s Emergency Plan for AIDS Research (PEPFAR). HIV/AIDS Epidemiology. HIV Therapeutics - Antiretroviral Drugs and Immune-Based Therapies: HIV Reverse Transcriptase, HIV Reverse Transcriptase Inhibitors: Nucleoside Analogues, Nucleotide Analogues: Tenofovir DF, Reverse Transcriptase Inhibitors: Non-Nucleoside Analogues, HIV Protease, HIV Protease Inhibitors, Fixed-Dose Combinations, Viral Entry/Fusion Inhibitors, Integrase Inhibitors, Maturation Inhibitors, HAART: Triple Highly Active Antiretroviral Combinations. Vaccine Development: Vaccine Clinical Trials, Vaccine Discovery and Development/Clinical Research, The Failure of the STEP Trial. Opportunistic Infections: Fungal Infections, Viral Infections, Parasitic Infections, Recent NIAID-Supported Clinical Studies in Opportunistic Infections. Part III. Immunoogy Research. Introduction. Mammalian Host defenses:Innate and Adaptivr Immunity. Immune Adjuvants. Immune Tollerance. Autoimmune Diseases. Mucosal Immune System. The Role of B-Cells. Transplantation. Asthma and Allergic Diseases.


Book
National Institute of Allergy and Infectious Diseases, NIH.
Authors: ---
ISBN: 1607615118 9786613054265 1607615126 1283054264 Year: 2010 Publisher: [Totowa, NJ] : Humana Press,

Loading...
Export citation

Choose an application

Bookmark

Abstract

National Institute of Allergy and Infectious Diseases, NIH: Volume III: Intramural Research contains a broad overview of the research activity of the NIAID intramural scientists working in the Division of Intramural Research (DIR) and the Vaccine Research Center (VRC), both in the Bethesda campus, and the Rocky Mountains Research Laboratories. Each of these laboratories employs scientists internationally recognized as leaders in their fields of biomedical research. This volume focuses on individual research contributions by internationally known scientists doing research in the NIAID laboratories.

Listing 1 - 10 of 24 << page
of 3
>>
Sort by